At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
Virtual Reality Biofeedback Sessionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Virtual Reality Biofeedback for Postpartum Anxiety and Depression
In Brief
A clinical study evaluating Virtual Reality Biofeedback Session for Anxiety and Depression and 2 related conditions. Completed, enrolled 6 participants across 1 site.
Detailed Summary
The purpose of this study is to test patient feasibility and acceptability of virtual reality biofeedback program in postpartum women for anxiety and depression outcomes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedJun 2021
Enrollment StartSep 2021
Primary CompletionSep 2021
Study CompletionOct 2021
TodayJul 2026
First PostedJun 14, 2021
Enrollment StartSep 1, 2021
Primary CompletionSep 30, 2021
Study CompletionOct 15, 2021
TodayJul 2, 2026
Enrollment to primary: 29 daysPosted 5.0 years ago
Interventions
Virtual Reality Biofeedback Sessionother
The "Flowly" intervention treatment utilizes virtual reality and biofeedback to train patients to auto-regulate themselves and improve their pain/anxiety/depression.